Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16.73 USD | -0.24% | +2.26% | +4.30% |
Jul. 02 | Innoviva, Inc.'s Subsidiary Innoviva Specialty Therapeutics, Inc. Appoints Patricia Drake as Chief Commercial Officer | CI |
Jun. 18 | Cantor Fitzgerald Initiates Innoviva at Overweight Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe1st Jan change | Capi. | |
---|---|---|
+4.30% | 1.04B | |
+62.66% | 854B | |
+40.42% | 636B | |
-4.37% | 361B | |
+17.16% | 324B | |
+9.87% | 301B | |
+15.66% | 247B | |
+17.90% | 228B | |
+14.86% | 177B | |
+0.45% | 164B |
- Stock Market
- Equities
- INVA Stock
- News Innoviva, Inc.
- Transcript : Innoviva, Inc., Q3 2017 Earnings Call, Oct 25, 2017